They can be either serous or mucinous
Clinical studies show that GLP-1 medications like semaglutide can lead to an average loss of up to 14.9% of starting body weight over 68 weeks
While these drugs inspire hope for a brighter outlook on managing type 1 diabetes, continued guidance and care from healthcare providers remain essential, due to the lack of official guidelines and comprehensive studies
Orthopaedic surgeons now prescribe them to help patients lose weight before knee surgery, while chest physicians use them for those with sleep apnea, a disorder that blocks the airway during sleep
For some people, it doesnt necessarily correlate with their medical conditions. Ali added that, regardless of the drug or the persons medical conditions, weight loss in obesity is a difficult, multifactorial problem that requires careful tailoring and commitment
Within a week, you will be matched with a healthcare professional who will assess your submission and determine whether GLP-1 medication is suitable for you